The main focus will be on nucleic acid-based as well as recombinant viral vector-based vaccine candidates as the most novel vaccine approaches, some of which have been recently and successfully employed for SARS-CoV-2 vaccines. Finally, some ideas will be presented on which methods to explore ...
The two are now known for doing important work on the Pfizer-BioNTech vaccine against the coronavirus. But they started their company to work on a cure for cancer. In fact, the doctors started a different company about 20 years ago...
We show here that the mRNA from anti-COVID vaccines is not detected in human breast milk samples collected 4-48 hours post-vaccine. These results strengthen the recommendation of ABM and WHO that lactating individuals who receive the anti-COVID-19 mRNA-based vaccine should continue to breast...
Pharma has a great opportunity ahead of it when it comes to conducting representative clinical trials. The industry’s application of mRNA techniques during the pandemic led to the fastest vaccine development in history. The processes used are now seeing
Indonesia's food and drugs agency (BPOM) greenlighted the use of Walvax Biotechnology's mRNA vaccine, which has been in development for more than two years and targets the original strain of the coronavirus. The approval comes as somewhat of a surprise as Walvax, which has been conducting lar...
Two mRNA vaccines from Pfizer and Moderna are nearing final approval, and both work by rewiring a genetic trigger. SARS-CoV-2, the virus that causes COVID-19 (coronavirus), has a unique physical structure that can be used to prime immune response. An mRNA vaccine has never been appr...
Both COVID and the flu have vaccines that prevent severe illness. No vaccine prevents illness 100%, but they can greatly reduce hospitalization and death. People aged six months and older are eligible to be vaccinated against both illnesses.1 ...
Vaccine. 2006;24:S1-10. Article Google Scholar Romanczuk H, Howley PM. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci. 1992;89(7):3159–63. Article ADS PubMed PubMed Central CAS Google ...
Kizzmekia Corbett, an immunologist at the US National Institutes of Health (NIH), is one of the scientists who in early 2020 helped to develop an mRNA-based vaccine for COVID-19. Developed in collaboration with biotech firm Moderna of Cambridge, Massachusetts, the vaccine is now being ...
S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592–598 (2013). Article ADS CAS Google Scholar Pelkmans, L. et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 436, 78–...